24,814 Shares in Sanofi (NASDAQ:SNY) Acquired by Northwest Bancshares Inc.

Northwest Bancshares Inc. acquired a new position in shares of Sanofi (NASDAQ:SNY - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 24,814 shares of the company's stock, valued at approximately $1,430,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Blair William & Co. IL acquired a new position in Sanofi during the first quarter worth $204,000. Clearbridge Investments LLC grew its holdings in shares of Sanofi by 3.2% during the first quarter. Clearbridge Investments LLC now owns 172,214 shares of the company's stock valued at $8,370,000 after buying an additional 5,411 shares in the last quarter. Lake Street Advisors Group LLC boosted its position in Sanofi by 24.8% during the first quarter. Lake Street Advisors Group LLC now owns 7,174 shares of the company's stock valued at $349,000 after purchasing an additional 1,426 shares during the last quarter. National Bank of Canada FI grew its stake in shares of Sanofi by 3.5% in the 1st quarter. National Bank of Canada FI now owns 350,895 shares of the company's stock valued at $17,281,000 after purchasing an additional 11,996 shares during the period. Finally, Pitcairn Co. acquired a new position in Sanofi during the 1st quarter worth $273,000. Hedge funds and other institutional investors own 10.04% of the company's stock.

Sanofi Stock Performance

Shares of SNY stock traded down $0.14 during trading on Wednesday, reaching $47.86. 644,713 shares of the company's stock traded hands, compared to its average volume of 2,040,489. The firm's 50-day moving average is $54.25 and its 200 day moving average is $52.22. The company has a current ratio of 1.00, a quick ratio of 0.65 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $121.46 billion, a P/E ratio of 24.49, a PEG ratio of 1.22 and a beta of 0.61. Sanofi has a 1 year low of $45.22 and a 1 year high of $58.97.

Sanofi (NASDAQ:SNY - Get Free Report) last issued its quarterly earnings results on Friday, October 25th. The company reported $1.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $1.35. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. The company had revenue of $13.44 billion during the quarter, compared to analyst estimates of $16.59 billion. During the same period last year, the business earned $2.55 EPS. Sanofi's quarterly revenue was up 12.3% compared to the same quarter last year. Equities research analysts expect that Sanofi will post 4.29 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently commented on SNY shares. StockNews.com cut shares of Sanofi from a "strong-buy" rating to a "buy" rating in a research report on Thursday, November 7th. Citigroup upgraded shares of Sanofi to a "strong-buy" rating in a research report on Tuesday, September 17th. Finally, Argus upped their price objective on shares of Sanofi from $55.00 to $60.00 and gave the company a "buy" rating in a research report on Friday, July 26th. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $57.50.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.